The global infection control market is witnessing significant growth, largely driven by advancements in sterilization techniques, ongoing clinical trials for infection control, a rising need for combating antibiotic resistance, and an increase in incidences of hospital-acquired infections.
Key observations from a recent market assessment include:
1. The consumables segment, including single-use items such as gloves and masks, dominated the infection control market, accounting for the highest revenue share in 2024.
2. Compared to other sectors, the services segment is projected to grow at an accelerated compound annual growth rate (CAGR) through the forecasting period.
3. With a market share of approximately 41.0% in 2024, the hospital segment dominated the market for infection control. This segment is also anticipated to grow at the fastest CAGR of 7.4% from 2024 to 2034.
4. In terms of geographical market shares, North America dominated the infection control market in 2024, accounting for over 31.0% of global revenue. The growth in this region is a result of effective healthcare policies and infection prevention practices, robust healthcare infrastructure, and a proactive approach to controlling drug-resistant organisms and potential pandemics.
5. In the Asia Pacific region, the market is expected to expand at the fastest CAGR of 8.3% over the forecast period from 2024 to 2034.
The U.S. infection control market alone was valued at USD 52.83 billion in 2024 and is projected to more than double, reaching around USD 102.67 billion by 2034. This growth will be supported by the diligent implementation of government strategies for public safety against infections and guidelines set by the Centers for Disease Control (CDC) for infection control.
Furthermore, the Asia Pacific region is poised for rapid growth, largely driven by an increased government focus on infection control policies, rising healthcare expenditure, and adoption of advanced technologies for infection control.
The integration of artificial intelligence (AI) in infection control offers promising potential in enabling early detection and efficient surveillance of potential outbreaks, promoting hand hygiene practices, and identifying potential contamination sources.
Increasingly, recurring infections in patients and the risks associated with hospital-acquired infections (HAIs) are catalyzing demand for efficient infection prevention measures. The promotion of antimicrobial stewardship programs (ASPs) by organizations such as the World Health Organization (WHO) is further fueling improvements in infection control practices.
It is therefore clear that the infection control market holds significant potential, driven by a combination of technological advancements, stringent government regulations, increased awareness about infection control measures, and the integration of AI and digital tools for improved efficacy and cost-effectiveness.